<div class="headers"><div>Figure 3. Least-square mean (LSM) reductions from baseline to week 8 in (A) mean sitting systolic blood pressure (msSBP) and (B) mean sitting diastolic blood pressure (msDBP) in subjects with and without the metabolic syndrome (MetS) at baseline. Error bars repre-sent standard error of the mean. A, aliskiren; AML, amlodipine.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>24(X)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p class="">Figure 3. Least-square mean (LSM) reductions from baseline to week 8 in (A) mean sitting systolic blood pressure (msSBP) and (B) mean sitting diastolic blood pressure (msDBP) in subjects with and without the metabolic syndrome (MetS) at baseline. Error bars repre-sent standard error of the mean. A, aliskiren; AML, amlodipine.</p></td>
</tr>
</tbody>
</table>
